TA
Tejal Ashok Vispute
About Tejal Ashok Vispute
Data last updated:
Tejal Ashok Vispute is a Director at Fido Pharma Private Limited (since 2020) and Director at Meibotan Private Limited (since 2022). The companies operate in Chemicals and Materials and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹20.59 Cr; the largest is Fido Pharma Private Limited at ₹20.59 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Mar 2020 | 2020 | ₹20.59 Cr (FY 2024) | Active | |
| Director | 13 Jun 2022 | 2022 | ₹10,880 (FY 2024) | Active |
Board colleagues of Tejal Ashok Vispute
| Name | DIN | Company | Designation |
|---|---|---|---|
| Parbhat Singh | 08717156 | Fido Pharma Private Limited , Meibotan Private Limited | Director |
| Ritu Raj Singh | 10186291 | Fido Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tejal Ashok Vispute
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejal Ashok Vispute
Tejal Ashok Vispute currently holds 2 directorships: Fido Pharma Private Limited (Director, since 04 Mar 2020, revenue ₹20.59 Cr (FY 2024)); Meibotan Private Limited (Director, since 13 Jun 2022, revenue ₹10,880 (FY 2024)).
Tejal Ashok Vispute was first appointed on 04 Mar 2020 as Director at Fido Pharma Private Limited. The most recent appointment on record is 13 Jun 2022 at Meibotan Private Limited.
The 2 current companies of Tejal Ashok Vispute that report revenue have a combined latest revenue of ₹20.59 Cr: Fido Pharma Private Limited ₹20.59 Cr (FY 2024); Meibotan Private Limited ₹10,880 (FY 2024).
The current boards of Tejal Ashok Vispute's companies include Parbhat Singh (Fido Pharma Private Limited), Ritu Raj Singh (Fido Pharma Private Limited).